Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$47.83M
89.14K shares
What this filing means
TAUB REBECCA plans to sell 89.14K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $47.83M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/20/2026ACC: 0001628280-26-002729
Director
Since Mar 2026
89.14K
Shares to sell
$47.83M
Approx. market value
2.24K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
1/16/2026
2.24KTotal acquired2.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/16/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 2.24K | — |
| Total | 2.24K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
18.65K
Market value
$9.75M
1/9/2026
—Completed
Units to sell
24.80K
Market value
$12.96M
1/9/2026
—Completed
Units to sell
18.65K
Market value
$10.30M
12/10/2025
—Completed
Units to sell
24.80K
Market value
$13.69M
12/10/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
2.24K
Market value
$1.12M
1/20/2026
Total
Units
89.14K
Value
$47.83M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/9/2026 | 18.65K | $9.75M | — | Completed |
1/9/2026 | 24.80K | $12.96M | — | Completed |
12/10/2025 | 18.65K | $10.30M | — | Completed |
12/10/2025 | 24.80K | $13.69M | — | Completed |
| Planned — Approximate Date | ||||
1/20/2026 | 2.24K | $1.12M | Nasdaq Stock Market | Planned |
| Total | 89.14K | $47.83M | ||